Latest Articles

  • In Reply: Classic diabetic ketoacidosis and the euglycemic variant
    Adi E. Mehta, MD and Robert Zimmerman, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 142-143; DOI: https://doi.org/10.3949/ccjm.92c.03003
  • In Reply: Insomnia in older adults
    Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005
  • Classic diabetic ketoacidosis and the euglycemic variant
    Param Darpan Sheth, MBBS
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 142; DOI: https://doi.org/10.3949/ccjm.92c.03002
  • Effective but inaccessible antiobesity medications
    Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001
  • Coronary artery bypass grafting: Practice trends and projections
    Coronary artery bypass grafting: Practice trends and projections
    Richard Ramsingh, MD and Faisal G. Bakaeen, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 181-191; DOI: https://doi.org/10.3949/ccjm.92a.23071

    Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.

  • Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
    Nicholas B. Cline, MD, Amudha Pazhanisamy, DO and David M. Lang, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 147-151; DOI: https://doi.org/10.3949/ccjm.92a.24054

    There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.

  • Cardiovascular disease in people living with HIV: Risk assessment and management
    Elizabeth Ghandakly, MD, JD, Rohit Moudgil, MD, PhD and Katherine Holman, MD
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 159-167; DOI: https://doi.org/10.3949/ccjm.92a.24055

    Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.

  • Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
    James Hekman, MD and Henry H. Ng, MD, MPH
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 168-170; DOI: https://doi.org/10.3949/ccjm.92a.24126

    The already higher cardiovascular risk in people living with HIV is exacerbated by social determinants of health such as socioeconomic status, access to healthcare, and systemic discrimination. Interventions that address this risk must be based in medical science and equity.

  • Which patients with presumed acute infectious diarrhea in an outpatient setting should undergo gastrointestinal pathogen panel testing?
    Brittany Jackson, MD, Sabrina Billings, MD, Dana M. Harris, MD, Jane Hata, PhD and Mary S. Hedges, MD
    Cleveland Clinic Journal of Medicine February 2025, 92 (2) 83-86; DOI: https://doi.org/10.3949/ccjm.92a.24084

    Use of a gastrointestinal pathogen panel is warranted in certain individuals, such as those with fever, visible blood in the stool, sepsis, or a compromised immune system.

  • Hypoglycemia after bariatric surgery: Management updates
    Anira Iqbal, MD and Vinni Makin, MBBS, MD
    Cleveland Clinic Journal of Medicine February 2025, 92 (2) 103-108; DOI: https://doi.org/10.3949/ccjm.92a.24033

    The authors discuss how to differentiate post-bariatric surgery hypoglycemia from other causes of hypoglycemia, highlight the evolving role of continuous glucose monitors in detecting it, and summarize management options.

Pages